Responsiveness of the Scripps neurologic rating scale during a multiple sclerosis clinical trial

被引:20
作者
Koziol, JA
Lucero, A
Sipe, JC
Romine, JS
Beutler, E
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Scripps Clin, Div Neurol, La Jolla, CA USA
关键词
D O I
10.1017/S0317167100000391
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The Scripps neurologic rating scale (SNRS) is a summary measure of individual components comprising a neurological examination, designed for use in multiple sclerosis (MS). Our objective is to evaluate the responsiveness of the SNRS, within the context of a 2-year, randomized, double-blind crossover study of the efficacy of cladribine for treatment of secondary progressive MS. Methods: Effect sizes were determined for the SNRS and its components, separately for each treatment group (initial placebo, and initial cladribine) over both years of the clinical trial, using a standard random effects model. Results: Individual components tended to show positive effect sizes (improvement) during periods of active therapy in both treatment groups, and negative effect sizes (deterioration) during periods of no active therapy. Summation indices derived from the individual components of the SNRS seemed somewhat more stable than the individual components. The two components mentation and mood, and bladder, bowel, or sexual dysfunction, were rather unresponsive in our clinical trial. Conclusions: Changes in the components of the SNRS over the course of our clinical trial were consistent between the two treatment groups. Most components were moderately responsive; and, the summary SNRS score appropriately summarized the moderate magnitudes of change evinced in the individual components.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 20 条
[1]   The treatment of chronic progressive multiple sclerosis with cladribine [J].
Beutler, E ;
Sipe, JC ;
Romine, JS ;
Koziol, JA ;
McMillan, R ;
Zyroff, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1716-1720
[2]  
Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.1016/B978-0-12-179060-8.50006-2
[3]   REPRODUCIBILITY AND RESPONSIVENESS OF HEALTH-STATUS MEASURES - STATISTICS AND STRATEGIES FOR EVALUATION [J].
DEYO, RA ;
DIEHR, P ;
PATRICK, DL .
CONTROLLED CLINICAL TRIALS, 1991, 12 (04) :S142-S158
[4]   DESIGN STRATEGIES IN MULTIPLE-SCLEROSIS CLINICAL-TRIALS [J].
ELLISON, GW ;
MYERS, LW ;
LEAKE, BD ;
MICKEY, MR ;
KE, D ;
SYNDULKO, K ;
TOURTELLOTTE, WW .
ANNALS OF NEUROLOGY, 1994, 36 :S108-S112
[5]  
Fitzpatrick R, 1992, Qual Health Care, V1, P89, DOI 10.1136/qshc.1.2.89
[6]   MEASURING CHANGE OVER TIME - ASSESSING THE USEFULNESS OF EVALUATIVE INSTRUMENTS [J].
GUYATT, G ;
WALTER, S ;
NORMAN, G .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (02) :171-178
[7]   Evaluating neurological outcome measures: The bare essentials [J].
Hobart, JC ;
Lamping, DL ;
Thompson, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02) :127-130
[8]   EFFECT SIZES FOR INTERPRETING CHANGES IN HEALTH-STATUS [J].
KAZIS, LE ;
ANDERSON, JJ ;
MEENAN, RF .
MEDICAL CARE, 1989, 27 (03) :S178-S189
[9]   A METHODOLOGICAL FRAMEWORK FOR ASSESSING HEALTH INDEXES [J].
KIRSHNER, B ;
GUYATT, G .
JOURNAL OF CHRONIC DISEASES, 1985, 38 (01) :27-36
[10]   A comparison of two neurologic scoring instruments for multiple sclerosis [J].
Koziol, JA ;
Frutos, A ;
Sipe, JC ;
Romine, JS ;
Beutler, E .
JOURNAL OF NEUROLOGY, 1996, 243 (03) :209-213